Log in to save to my catalogue

283 Quantifying muscle amyloid in inclusion body myositis using pet

283 Quantifying muscle amyloid in inclusion body myositis using pet

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2115137751

283 Quantifying muscle amyloid in inclusion body myositis using pet

About this item

Full title

283 Quantifying muscle amyloid in inclusion body myositis using pet

Publisher

London: BMJ Publishing Group LTD

Journal title

Journal of neurology, neurosurgery and psychiatry, 2018-10, Vol.89 (10), p.A42-A43

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

ObjectivesInclusion body myositis (IBM) shares some histopathological features with polymyositis (PM). Current investigations have low sensitivity for identification of amyloid deposits that are characteristic of IBM, contributing to frequent misdiagnosis. We compared muscle amyloid content, quantified using a novel positron emission tomography (PE...

Alternative Titles

Full title

283 Quantifying muscle amyloid in inclusion body myositis using pet

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2115137751

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2115137751

Other Identifiers

ISSN

0022-3050

E-ISSN

1468-330X

DOI

10.1136/jnnp-2018-ABN.147

How to access this item